Biocardia Inc (BCDA) Annual Balance Sheets

Annual · GAAP · USD millions
Access BCDA quarterly Balance Sheets →
This page allows investors to track Biocardia Inc's balance sheet development across multiple reporting periods.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent2.50
Cash & Short-term Investments2.00
Accounts receivable0.02
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.22
Total Current Assets2.73
Equipment/Property/Plant Net0.02
Other Assets, Noncurrent0.67
Operating Lease Right Of Use Asset0.49
Total Assets3.41
Liabilities
Accounts Payable, Current AC0.64
Other Liabilities, Current1.79
Total Current Liabilities2.43
Total Long-term Debt0.00
Other liabilities, Noncurrent0.09
Accrued Liabilities And Other Liabilities Current1.35
Operating Lease Liability Noncurrent0.09
Total Liabilities2.52
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock169.23
Retained Earnings / Accumulated Deficit-168.35
Other Equity0.00
Common Stockholder's Equity0.90
Total Stockholder's Equity0.90
Liabilities & Stockholder's Equity3.41
4 historic quarters locked

Sign in to unlock the full Biocardia Inc balance sheet history.

About Biocardia Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-009587

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.